261 related articles for article (PubMed ID: 21818819)
21. Sensitivity of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice.
Huff K; Stark PC; Solomon LW
Gen Dent; 2009; 57(1):34-8. PubMed ID: 19146141
[TBL] [Abstract][Full Text] [Related]
22. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review.
Rashid A; Warnakulasuriya S
J Oral Pathol Med; 2015 May; 44(5):307-28. PubMed ID: 25183259
[TBL] [Abstract][Full Text] [Related]
23. Patterns of differentially expressed genes in oral mucosal lesions visualised under autofluorescence (VELscope(™) ).
Kordbacheh F; Bhatia N; Farah CS
Oral Dis; 2016 May; 22(4):285-96. PubMed ID: 26749103
[TBL] [Abstract][Full Text] [Related]
24. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device.
Poh CF; Ng SP; Williams PM; Zhang L; Laronde DM; Lane P; Macaulay C; Rosin MP
Head Neck; 2007 Jan; 29(1):71-6. PubMed ID: 16983693
[TBL] [Abstract][Full Text] [Related]
25. The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions.
McNamara KK; Martin BD; Evans EW; Kalmar JR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):636-43. PubMed ID: 23083477
[TBL] [Abstract][Full Text] [Related]
26. [Autofluorescence for the detection of potentially malignant and malignant lesions of the oral cavity lining].
Fricain JC
Rev Stomatol Chir Maxillofac; 2011 Feb; 112(1):16-21. PubMed ID: 21257187
[TBL] [Abstract][Full Text] [Related]
27. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
28. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope™) - a single blinded clinical evaluation.
Hanken H; Kraatz J; Smeets R; Heiland M; Assaf AT; Blessmann M; Eichhorn W; Clauditz TS; Gröbe A; Kolk A; Rana M
Head Face Med; 2013 Aug; 9():23. PubMed ID: 23967796
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial.
Koch FP; Kaemmerer PW; Biesterfeld S; Kunkel M; Wagner W
Clin Oral Investig; 2011 Dec; 15(6):975-82. PubMed ID: 20714910
[TBL] [Abstract][Full Text] [Related]
30. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
31. Exfoliative cytology in screening for malignant and premalignant lesions in the buccal mucosa.
Ramaesh T; Ratnatunga N; Mendis BR; Rajapaksa S
Ceylon Med J; 1998 Dec; 43(4):206-9. PubMed ID: 10355174
[TBL] [Abstract][Full Text] [Related]
32. Autofluorescence imaging in recurrent oral squamous cell carcinoma.
Scheer M; Fuss J; Derman MA; Kreppel M; Neugebauer J; Rothamel D; Drebber U; Zoeller JE
Oral Maxillofac Surg; 2016 Mar; 20(1):27-33. PubMed ID: 26267490
[TBL] [Abstract][Full Text] [Related]
33. Vision enhancement system for detection of oral cavity neoplasia based on autofluorescence.
Svistun E; Alizadeh-Naderi R; El-Naggar A; Jacob R; Gillenwater A; Richards-Kortum R
Head Neck; 2004 Mar; 26(3):205-15. PubMed ID: 14999795
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of objective VELscope fluorescence methods in distinguishing oral cancer from oral potentially malignant disorders (OPMDs).
Wang C; Qi X; Zhou X; Liu H; Li M
Transl Cancer Res; 2022 Jun; 11(6):1603-1615. PubMed ID: 35836514
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
[TBL] [Abstract][Full Text] [Related]
36. The diagnostic value of the native fluorescence visualization device for early detection of premalignant/malignant lesions of the oral cavity.
Amirchaghmaghi M; Mohtasham N; Delavarian Z; Shakeri MT; Hatami M; Mosannen Mozafari P
Photodiagnosis Photodyn Ther; 2018 Mar; 21():19-27. PubMed ID: 29079347
[TBL] [Abstract][Full Text] [Related]
37. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa.
Trullenque-Eriksson A; Muñoz-Corcuera M; Campo-Trapero J; Cano-Sánchez J; Bascones-Martínez A
Med Oral Patol Oral Cir Bucal; 2009 May; 14(5):E210-6. PubMed ID: 19218907
[TBL] [Abstract][Full Text] [Related]
38. Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring.
Paderni C; Compilato D; Carinci F; Nardi G; Rodolico V; Lo Muzio L; Spinelli G; Mazzotta M; Campisi G
Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):121-8. PubMed ID: 21781457
[TBL] [Abstract][Full Text] [Related]
39. [The clinical evaluation of Oratest in detecting oral mucosal lesions].
Cheng B; Yang L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):124-6. PubMed ID: 12838698
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of oral premalignant and malignant lesions using cytomorphometry.
Ramaesh T; Mendis BR; Ratnatunga N; Thattil RO
Odontostomatol Trop; 1999 Mar; 22(85):23-8. PubMed ID: 11372099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
